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HUMAN BODY AS A MULTICRINE GLAND 
Th e present Editorial is a refl ection from the article by Stephen 
Manning (1) and by Sridhar Gumpeny and Lakshmi Gumpeny 
(2) published in this volume of Adipobiology. Focusing to in-
jured Homo obesus (1) and glucose and energy homeostasis (2), 
the authors also discussed adipose- and bone-derived endocrine 
proteins collectively termed adipokines and osteokines, respec-
tively. 
Here, we introduce the term “multicrine” to embodying vari-
ous secretory phenomena including exo-, endo-, para-, auto-, 
intra- and juxtacrine, also retrocrine (3,4) and necrocrine (5,6) 
pathways. Th eir fi nal products are: enzymes, protein and ster-
oid hormones, cytokines, chemokines, cardiokines, enterokines, 
adipokines, myokines, and osteokines. For NGF as neurokine, 
see Rita Levi-Montalcini et al in Trends Neurosci 1996; 19:514-
520; for NGF and BDNF as metabokines, see Chaldakov et al in 
Riv Psichiatr 2009; 44:79-87.
Traditionally, the endocrine system consists of glands, each 
releasing hormones into the bloodstream, whereas the exocrine 
glands discharging enzymes into the ductstream/lumens. In ad-
dition to the “classical” endocrine organs, many other organs 
that are part of other body systems, such as the heart and kidney, 
also produce and release endocrine products; for instance, heart 
secretes natriuretic peptides (see below) and kidney secretes 
erythropoietin and renin. Certain glands communicate each 
other in sequence thus creating axis, for example, the hypoth-
alamic-pituitary-adrenal axis. Recently, many other axises have 
been recognized, e.g. adipose-brain axis, adipose-bone axis, 
muscle-adipose axis and entero-insular axis (see below).
According to Palade-Blobel’s paradigm, the process of protein 
secretion is mediated by synthesis, post-translational modifi ca-
tion and folding, and sorting and targeting to fi nal destinations 
including plasma membrane, nucleus, intracellular organelles, 
or exocytosis. Briefl y, the three major types of secretory prod-
ucts are plasmalemmal, intracellular (imported) and exported 
proteins (7,8). Further, non-rough endoplasmic reticulum-Gol-
gi complex pathways using multivesicular endosome-derived 
exosomes and plasmalemma-shedding microparticles termed 
ectosomes are also appreciated in the recent studies of cell secre-
tion (Fig. 1). 
Figure 1. Schematic illustration of a “multicrine cell”. The ar-
rows, left from up-to-down, indicate endocrine, paracrine 
and autocrine pathway; other two arrows show exosomes 
and ectosomes. The arrow targeted the nucleus indicates an 
intracrine pathway
Adipose tissue and adipokines
Th e most momentous challenge that has occurred in the end of 
1994 has been the discovery of leptin, an adipocyte-secreted Ob 
gene-encoded protein (9). Th is became an acute trigger for the 
current development of adipobiology, particularly the studies on 
adipose-derived signaling protein designated adipokines (8,10-
14). 
Diff use neuroendocrine system and hormones 
Historically, Nikolai Konstantinovich Kulchitsky (1856-1925) 
has identifi ed the enterochromaffi  n cells found in the crypts of 
Lieberkuhn of gastrointenstinal mucosa, in 1897. Th is discovery 
formed the basis for the subsequent delineation of the diff use neu-
roendocrine system (DNES) by Friedrich Feyrter in 1938; exam-
ples of DNES include Feyrter’s Hellen Zellen (clear cells) in pan-
creas and gut, hepatic stellate cells (Ito cells), testicular Leydig cells 
and other cells disseminated throughout the body (15), adipose 
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tissue (16,17) and circulating immune cells (18,19) being intro-
duced into the DNES. The pro-opiomelanocortin (POMC) gene 
encodes a family of peptides originally identified in the pituitary 
gland. An important POMC-derived peptide hormone, cortico-
tropin (ACTH), is also produced by leukocytes (18).
Heart and cardiokines 
Knowledge of the cardiac endocrine function was initiated with 
the discovery of “specific granules” found in the atrial cardio-
myocytes of experimental animals examined with transmission 
electron microscope by Jemieson and Palade (20). Onward, the 
granules’ content was found to consist of two different peptides 
with similar biological effects: A- and B-type natriuretic pep-
tides (21).
Gut and enterokines
Certain intestinal mucosal cells synthesize and release hor-
mones (enterokines) termed incretins. These include glucagon-
like peptide-1 (GLP-1) and glucose-dependent insulinotropic 
polypeptide (GIP), both of which promote proliferation of pan-
creatic beta cells and prevent their apoptosis (22). Incretins also 
contribute to insulin secretion from the beginning of a meal and 
their effects are progressively amplified as plasma glucose con-
centrations rise. The current interest in these enterokines is due 
to the fact that their effects are severely reduced or absent in 
patients with type 2 diabetes mellitus, thus representing a novel 
therapeutic target for this disease (23,24).
Skeletal muscles and myokines
Recently, skeletal muscles - in response to contraction - also 
“became” an endocrine gland. They produce and release inter-
leukin-6 (IL-6), IL-15 and adiponectin (25-30), leukemia inhibi-
tory factor (31, as a paracrine signal), BDNF (32,33) and my-
ostatin, or growth differentiation factor 8 (GDF-8) (34). These 
molecules are collectively termed myokines. Accumulating find-
ings suggest that myokines may exert specific effects on adipose 
tissue as well as mediating anti-inflammatory, anti-obesogenic 
and insulin-sensitizing effects. 
Skeleton and osteokines
The skeleton has recently emerged as an endocrine organ with 
effects on body weight control and glucose homeostasis through 
the actions of bone-derived signaling protein (osteokines) such 
as osteocalcin and osteopontin (1,2,35,36). The cross-talk be-
tween the adipose tissue and the skeleton constitutes a homeo-
static feedback system operating with osteokines and adipokines 
in a bone-adipose axis (35,36).
Altogether, the human body may be considered a multicrine 
gland delivering a large number of peptides and proteins (also 
steroids and other signaling molecules) which control a large 
scale of biological processes in health and disease.
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